Dr. Bo Feng is a Sr. Director in the Department of Drug Metabolism & Pharmacokinetics at Vertex Pharmaceuticals. She earned her Ph.D. from the Department of Pharmaceutical Sciences, University of Nebraska Medical Center in 1999. Following graduate school, she completed a postdoctoral fellowship with Professor Kathleen Giacomini in the Department of Biopharmaceutical Science at University of California, San Francisco. In 2002, she joined Pfizer to lead a drug transporter group. In 2019, she joined Vertex Pharmaceuticals, and is leading the In vitro ADMET team. She continues to develop transporter and drug metabolizing enzyme strategies to support discovery and development portfolio. Her research interests include using transporter and metabolizing enzyme studies to develop in vitro to in vivo extrapolation and translational approaches to predict drug-drug interaction, toxicity, drug disposition and clearance. She has authored and coauthored over 60 original articles/reviews/book chapters and has given invited oral presentations at many scientific conferences.